Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Location
Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
Telephone Numbers
Customer Service: (800) 227-6666 / (650) 697-3600
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-B9762-50 | 50 µl (0.5 mg/ml) | $460 |
1 of 2
2 of 2
Polyclonal Rabbit anti‑Human LILRB2 / ILT4 Antibody (C‑Terminus, IHC, WB) LS‑B9762
Polyclonal Rabbit anti‑Human LILRB2 / ILT4 Antibody (C‑Terminus, IHC, WB) LS‑B9762
Note: This antibody replaces LS-C146558
Toll Free North America
(800) 227-6666
(800) 227-6666For Research Use Only
Overview
Specifications
Description
ILT4 antibody LS-B9762 is an unconjugated rabbit polyclonal antibody to human ILT4 (LILRB2) (C-Terminus). Validated for IHC and WB. Cited in 1 publication.
Target
Human LILRB2 / ILT4
Synonyms
LILRB2 | CD85D | CD85d antigen | Ig-like transcript 4 | LIR-2 | MIR-10 | MIR10 | ILT-4 | ILT4 | LIR2
Host
Rabbit
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Purification
Immunoaffinity purified
Modifications
Unmodified
Immunogen
Synthetic peptide from C-Terminus of human LILRB2 (Q8N423, NP_005865). Percent identity by BLAST analysis: Human, Gorilla (100%); Chimpanzee, Gibbon, Monkey (92%); Marmoset (91%); Baboon (85%).
Epitope
C-Terminus
Specificity
Human LILRB2
Applications
- IHC
- IHC - Paraffin (10 µg/ml)
- Western blot (1 µg/ml)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, 0.09% sodium azide, 2% sucrose
Storage
Short term: Store at 2-8°C. Long term: Aliquot and store at -20°C. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
About LILRB2 / ILT4
LSBio Ratings
LILRB2 / ILT4 Antibody (C-Terminus) for IHC, WB/Western LS-B9762 has an LSBio Rating of
Publications (4)
Learn more about The LSBio Ratings Algorithm
Publications (1)
Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma. Kevin T Lynch, Samuel J Young, Max O Meneveau, Nolan A Wages, Victor H Engelhard, Craig L Slingluff Jr, Ileana S Mauldin. Journal for immunotherapy of cancer. 2021 June;9:
Customer Reviews (0)
Featured Products
Species:
Human, Mouse
Applications:
Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human
Applications:
Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 12/21/2024
Date Requested: 12/21/2024
